|
SELT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.781770E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.854250E-02 |
| Normal-vs-Stage2 |
5.806600E-01 |
| Normal-vs-Stage3 |
5.025900E-02 |
| Normal-vs-Stage4 |
2.020000E-02 |
| Stage1-vs-Stage2 |
2.189600E-01 |
| Stage1-vs-Stage3 |
8.909400E-01 |
| Stage1-vs-Stage4 |
4.137000E-01 |
| Stage2-vs-Stage3 |
3.611400E-01 |
| Stage2-vs-Stage4 |
1.955960E-01 |
| Stage3-vs-Stage4 |
4.001400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.419100E-03 |
| Normal-vs-AfricanAmerican |
1.790240E-01 |
| Normal-vs-Asian |
2.882200E-01 |
| Caucasian-vs-AfricanAmerican |
3.865800E-01 |
| Caucasian-vs-Asian |
9.178800E-01 |
| AfricanAmerican-vs-Asian |
8.444400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.657610E-02 |
| Normal-vs-Female |
4.106400E-01 |
| Male-vs-Female |
3.846400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.755900E-02 |
| Normal-vs-Extreme_Weight |
1.448180E-02 |
| Normal-vs-Obese |
1.482270E-02 |
| Normal-vs-Extreme_Obese |
2.154600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.061400E-01 |
| Normal_Weight-vs-Obese |
8.745600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.307400E-01 |
| Extreme_Weight-vs-Obese |
9.700200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.732400E-01 |
| Obese-vs-Extreme_Obese |
8.370800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.955800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.265580E-01 |
| Normal-vs-Age(61-80Yrs) |
9.001600E-03 |
| Normal-vs-Age(81-100Yrs) |
8.338500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.568800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.994400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.522000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.781200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.879800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.589600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.252010E-01 |
| Normal-VS-Type2 PRCC |
3.299100E-03 |
| Normal-VS-KIRP CIMP |
1.392190E-02 |
| Normal-VS-Unclassified PRCC |
5.539900E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.097700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.069400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.003400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.491600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.539600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.799800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.804500E-03 |
| Normal-vs-N1 |
1.061500E-02 |
| Normal-vs-N2 |
1.261720E-02 |
| N0-vs-N1 |
8.010000E-01 |
| N0-vs-N2 |
3.396000E-01 |
| N1-vs-N2 |
2.461400E-01 |
|
|
